-transparent.png){kind=logo}
The activity of pyroglutamate aminopeptidase, the major enzyme catalyzing thyrotropin-releasing hormone (TRH) metabolism in human CSF, decreased with age. This decrement is not due to age-dependent appearance of any enzyme inhibitor in CSF. The results of these studies underline the importance of using age-matched controls in assessing abnormalities of TRH metabolism in CSF during disease states.
Related Publications
C Prasad, and
H J Robertson, and
A Jayaraman, and
J K Rao
February 1986,
Brain research,
C Prasad, and
H J Robertson, and
A Jayaraman, and
J K Rao
November 1963,
Neurology,
C Prasad, and
H J Robertson, and
A Jayaraman, and
J K Rao
April 1967,
Indian journal of pathology & bacteriology,
C Prasad, and
H J Robertson, and
A Jayaraman, and
J K Rao
January 2012,
PloS one,
C Prasad, and
H J Robertson, and
A Jayaraman, and
J K Rao
January 1979,
Experientia,
C Prasad, and
H J Robertson, and
A Jayaraman, and
J K Rao
January 1998,
Dementia and geriatric cognitive disorders,
C Prasad, and
H J Robertson, and
A Jayaraman, and
J K Rao
December 1969,
Wiener klinische Wochenschrift,
C Prasad, and
H J Robertson, and
A Jayaraman, and
J K Rao
December 1962,
Klinische Wochenschrift,
C Prasad, and
H J Robertson, and
A Jayaraman, and
J K Rao
June 1987,
Biochemical medicine and metabolic biology,
C Prasad, and
H J Robertson, and
A Jayaraman, and
J K Rao
October 1992,
Indian journal of biochemistry & biophysics,
